SCHEDULE 13D SUBMISSION

Company

Alaunos Therapeutics, Inc.

Filed

August 18, 2006

Accession Number

0000851909-06-000016

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →